US
VanEck Biotech ETF
BBH · Equity
$188
+1.76%
Assets
n/a
Expense ratio
0.35%
Holdings
25
1Y return
+35.2%
Forward P/E
n/a
Top 10 holdings
+69.5%
Return and risk
| 1Y total return | +35.2% |
| 3Y total return | +20.3% |
| 5Y total return | +9.6% |
| 3Y CAGR | +6.4% |
| 5Y CAGR | +1.9% |
| Beta | 0.72 |
| RSI | 52.49 |
Fund structure
| Asset class | Equity |
| Assets | n/a |
| Holdings | 25 |
| Expense ratio | 0.35% |
| Dividend yield | +0.5% |
| Top 10 holdings | +69.5% |
| Volume | 6.2K |
All ETF indicators
| All Time High | 222.22 |
| All Time High Change | -15.2 |
| All Time High Date | 2021-08-10 |
| All Time Low | 35.04 |
| All Time Low Change | 437.74 |
| All Time Low Date | 2011-12-21 |
| Atr | 2.87 |
| Beta | 0.72 |
| Cagr10y | 6.65 |
| Cagr1y | 35.25 |
| Cagr3y | 6.36 |
| Cagr5y | 1.86 |
| Ch10y | 82.21 |
| Ch1m | 1.02 |
| Ch1w | 1.53 |
| Ch1y | 34.55 |
| Ch3m | -3.72 |
| Ch3y | 18.26 |
| Ch5y | 7.04 |
| Ch6m | 0.74 |
| Ch YTD | -0.44 |
| Close | 185.15 |
| Div CAGR10 | 11.33 |
| Div CAGR3 | 10.3 |
| Div CAGR5 | 19.22 |
| Dividend Growth | -23.58 |
| Dividend Growth Years | 0 |
| Dividend Years | 11 |
| Dividend Yield | 0.51 |
| Dps | 0.96 |
| Ex Div Date | 2025-12-22 |
| High52 | 202.91 |
| High52ch | -7.15 |
| High52 Date | 2026-01-27 |
| Inception Date | 2011-12-20 |
| Isin | US92189F7261 |
| Last Dividend | 0.96 |
| Low52 | 140.17 |
| Low52ch | 34.41 |
| Low52 Date | 2025-05-15 |
| Ma150 | 189.01 |
| Ma150ch | -0.3 |
| Ma20 | 187.54 |
| Ma200 | 183.12 |
| Ma200ch | 2.91 |
| Ma20ch | 0.48 |
| Ma50 | 187.6 |
| Ma50ch | 0.45 |
| Payment Date | 2025-12-26 |
| Payout Frequency | Annual |
| Payout Ratio | 11.32 |
| Price Date | 2026-05-12 |
| Rsi | 52.49 |
| Rsi Monthly | 58.14 |
| Rsi Weekly | 52.29 |
| Sharpe Ratio | 1.43 |
| Sortino Ratio | 2.59 |
| Top10holdings | 69.5 |
| Tr10y | 90.42 |
| Tr1m | 1.02 |
| Tr1y | 35.23 |
| Tr3m | -3.72 |
| Tr3y | 20.33 |
| Tr5y | 9.63 |
| Tr6m | 1.24 |
| Tr YTD | -0.44 |